On Tuesday, the company said it seeks approval of the booster shots for people above 18 years.
"Our clinical program has found that a booster of our COVID-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent. We look forward to our discussions with the FDA and other health authorities to support their decisions regarding boosters," said Janssen Research & Development Head Mathai Mammen. "At the same time, we continue to recognize that a single-shot COVID-19 vaccine that provides strong and long-lasting protection remains a crucial component to vaccinating the global population."
On September 27, U.S. President Biden received Pfizer’s booster shot.